More on CRIS
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Research and development | |
| License fees | |
| Total revenues | 1.76M |
| Research and development | |
| General and administrative | 4.68M |
| Total costs and expenses | 29.55M |
| (Loss)/income from operations | -27.79M |
| Interest income | 101K |
| Change in fair value of warrant liability | -556K |
| Total other (expense)/income | |
| Net (loss)/income | -28.35M |
| Basic net (loss)/income per common share | |
| Diluted net (loss)/income per common share | |
| Basic weighted average common shares | |
| Diluted weighted average common shares | |
| Net (loss)/income | |
| Unrealized (loss)/income on marketable securities | |
| Comprehensive (loss)/income | |
Entities mentioned with CRIS
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- S3 | View Related Stories »
- Robert W Baird | View Related Stories »
- Definitive Agreement | View Related Stories »
- Roth Capital | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
